Bio Developments

(Image: Getty/Dragana991)

A troubled timeline of Alzheimer’s trials

By Ben Hargreaves

After Biogen’s setback in the space, the number of treatments that have not succeeded in making an impact on Alzheimer’s disease continues to grow.

Follow us

Products

View more

Webinars